News Conference News ACC 2026 Hints of a Mortality Benefit With TTVR at 2 Years TRISCEND II Yael L. Maxwell April 07, 2026
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2020 Early Data Support TAVR in Bicuspid Valves, but Questions Remain Michael O'Riordan March 29, 2020
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019